Supriya Lifescience Limited (SUPRIYA) — Financial Flexibility Index
Supriya Lifescience Limited (SUPRIYA) has a Financial Flexibility Index of 0.81x as of September 2025. Free cash flow of Rs978.14 Million (operating CF Rs555.65 Million minus capex Rs422.49 Million) represents 1% of total liabilities (Rs1.21 Billion). Check total reinvestment intensity of Supriya Lifescience Limited to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Supriya Lifescience Limited Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Supriya Lifescience Limited across 8 annual periods. For the full cash flow conversion analysis, see SUPRIYA cash generation efficiency.
Annual Financial Flexibility Index for Supriya Lifescience Limited (2018–2025)
Year-by-year free cash flow to debt coverage for Supriya Lifescience Limited. Explore Supriya Lifescience Limited (SUPRIYA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.90x | Rs3.35 Billion | Rs1.73 Billion | Rs1.16 Billion | ▲ +18.5% |
| 2024 | 2.45x | Rs2.59 Billion | Rs1.13 Billion | Rs1.06 Billion | ▲ +69.3% |
| 2023 | 1.45x | Rs1.75 Billion | Rs661.87 Million | Rs1.21 Billion | ▲ +58.3% |
| 2022 | 0.91x | Rs1.09 Billion | Rs488.01 Million | Rs1.19 Billion | ▲ +26.0% |
| 2021 | 0.72x | Rs1.28 Billion | Rs799.30 Million | Rs1.77 Billion | ▼ -3.5% |
| 2020 | 0.75x | Rs1.41 Billion | Rs1.16 Billion | Rs1.87 Billion | ▲ +115.0% |
| 2019 | 0.35x | Rs556.17 Million | Rs486.72 Million | Rs1.59 Billion | ▲ +197.6% |
| 2018 | 0.12x | Rs223.82 Million | Rs174.52 Million | Rs1.91 Billion | — |